Jazz Pharmaceuticals plc Watch

from 8-K 220 pages Credit Agreement Dated as of May 5, 2021 Among Jazz Pharmaceuticals Public Limited Company, as Parent and an Irish Borrower, JAZZ Securities Designated Activity Company, as an Irish Borrower, JAZZ Financing Lux S.À R.L., as a Lux Borrower, JAZZ Financing I Designated Activity Company, as an Irish Borrower, Jazz Pharmaceuticals Ireland Limited, as an Irish Borrower, JAZZ Financing Holdings Limited, as an Irish Borrower Jazz Pharmaceuticals Uk Holdings Limited, as a Uk Borrower, and JAZZ Pharmaceuticals, Inc., as a U.S. Borrower, the Other Subsidiaries of Parent Named Herein, as Designated Borrowers, the Lenders Party Hereto, Bank of America, N.A., as Administrative Agent, U.S. Bank National Association, as Collateral Trustee, and Bank of America, N.A., Jpmorgan Chase Bank, N.A., Barclays Bank PLC, Citigroup Global Markets Inc., Credit Suisse Loan Funding LLC, Dnb (Uk) Ltd., Mufg Bank, Ltd., Rbc Capital Markets Llc1, Sumitomo Mitsui Banking Corporation and Truist Securities, Inc., as Joint Lead Arrangers and Joint Bookrunners

from 10-Q 230 pages Amendment No. 2, Dated as of June 7, 2018 (This “Amendment”), to the Credit Agreement, Dated as of June 18, 2015, by and Among Jazz Pharmaceuticals Public Limited Company, a Public Limited Company Organized Under the Laws of Ireland (“Parent”), JAZZ Securities Designated Activity Company (F/K/a JAZZ Securities Limited), a Section 110 Designated Activity Company Incorporated Under the Laws of Ireland (The “Lead Borrower”), JAZZ Pharmaceuticals, Inc., a Delaware Corporation (The “U.S. Borrower”), JAZZ Financing I Designated Activity Company (F/K/a JAZZ Financing I Limited), a Designated Activity Company Incorporated Under the Laws of Ireland (“JAZZ Financing I”), Jazz Pharmaceuticals Ireland Limited, a Company Incorporated Under the Laws of Ireland (Together With the Lead Borrower and JAZZ Financing I, the “Irish Borrowers” And, Together With the U.S. Borrower, the “Borrowers” and Each, a “Borrower”), the Lenders From Time to Time Party Thereto and Bank of America, N.A., as Administrative Agent (The “Administrative Agent”), Collateral Agent, Swing Line Lender and L/C Issuer (As Amended by Amendment No. 1, Dated as of July 12, 2016, and as Further Amended, Restated, Modified and Supplemented Prior to the Date Hereof, the “Original Credit Agreement”); Capitalized Terms Used and Not Otherwise Defined Herein Shall Have the Meanings Assigned to Such Terms in the Amended Credit Agreement (As Defined Below). Whereas, the Borrowers Desire to Amend the Original Credit Agreement to Effect the Amendments Set Forth Herein Pursuant to Section 10.01 of the Original Credit Agreement;

from 10-Q 240 pages Amendment No. 1, Dated as of July 12, 2016 (This “Amendment”), to the Credit Agreement, Dated as of June 18, 2015, by and Among Jazz Pharmaceuticals Public Limited Company, a Public Limited Company Organized Under the Laws of Ireland (“Parent”), JAZZ Securities Limited, a Section 110 Company Incorporated Under the Laws of Ireland (The “Lead Borrower”), JAZZ Pharmaceuticals, Inc., a Delaware Corporation (The “U.S. Borrower”), JAZZ Financing I Limited, a Company Incorporated Under the Laws of Ireland (“JAZZ Financing I”), Jazz Pharmaceuticals Ireland Limited, a Company Incorporated Under the Laws of Ireland (Together With the Lead Borrower and JAZZ Financing I, the “Irish Borrowers” And, Together With the U.S. Borrower, the “Borrowers” and Each, a “Borrower”), the Lenders From Time to Time Party Thereto and Bank of America, N.A., as Administrative Agent (The “Administrative Agent”), Collateral Agent, Swing Line Lender and L/C Issuer (As Amended, Restated, Modified and Supplemented Prior to the Date Hereof, the “Original Credit Agreement”); Capitalized Terms Used and Not Otherwise Defined Herein Shall Have the Meanings Assigned to Such Terms in the Amended Credit Agreement (As Defined Below)

from 8-K 199 pages $1,500,000,000 Credit Agreement Dated as of June 18, 2015, Among Jazz Pharmaceuticals Public Limited Company, as Parent, JAZZ Securities Limited, as Lead Borrower, JAZZ Pharmaceuticals, Inc., as U.S. Borrower, Jazz Pharmaceuticals Ireland Limited, as an Irish Borrower, JAZZ Financing I Limited, as an Irish Borrower, the Lenders From Time to Time Party Hereto, Bank of America, N.A., as Administrative Agent, Collateral Agent, L/C Issuer and Swing Line Lender, Barclays Bank PLC, Citibank, N.A., Dnb (Uk) Limited Jpmorgan Chase Bank, N.A., and Royal Bank of Canada, as Co-Syndication Agents, Credit Suisse AG, Cayman Islands Branch Hsbc Bank PLC, Morgan Stanley Bank, N.A., Mufg Union Bank, N.A., Sumitomo Mitsui Banking Corporation, New York Branch, and Suntrust Bank, as Co-Documentation Agents, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Bank PLC, Citigroup Global Markets, Inc., Dnb (Uk) Limited, J.P. Morgan Securities LLC, and Rbc Capital Markets as Joint Lead Arrangers and Joint Bookrunners

from 10-K 200 pages Amendment 2 to Credit Agreement

from 8-K 177 pages $575,000,000 Credit Agreement Dated as of June 12, 2012 Among Jazz Pharmaceuticals Public Limited Company, as Parent, JAZZ Pharmaceuticals, Inc., as Borrower, the Lenders From Time to Time Party Hereto, Barclays Bank PLC, as Administrative Agent, Collateral Agent, L/C Issuer and Swing Line Lender, Barclays Bank PLC, as Sole Lead Arranger, Barclays Bank PLC, Citigroup Global Markets, Inc. and J.P. Morgan Securities LLC, as Joint Bookrunners, Citibank, N.A. and Jpmorgan Chase Bank, N.A., as Co-Syndication Agents and Royal Bank of Canada and Suntrust Bank, as Co-Documentation Agents

from 8-K 110 pages $65,000,000 Senior Secured Credit Facilities Credit Agreement Among Jazz Pharmaceuticals, Inc. and Jpi Commercial, LLC, as the Borrowers, the Several Lenders From Time to Time Parties Hereto, and Silicon Valley Bank, as Administrative Agent, Issuing Lender and Swingline Lender Dated as of June 28, 2010